Cardiff Oncology (CRDF) Proxy filing summary

Executive summary

• Special Meeting of Stockholders scheduled for October 22, 2026, at company headquarters in San Diego, CA.

• Proxy materials are available online, with options to request paper or email copies at no charge.

• Voting can be conducted online, by mail, or in person at the meeting.

Voting matters and shareholder proposals

• Proposal 1 seeks approval to amend the Certificate of Incorporation to increase authorized capital stock from 170,000,000 to 320,000,000 and common stock from 150,000,000 to 300,000,000.

• Proposal 2 requests approval to adjourn the meeting if more time is needed to solicit votes for Proposal 1.

• Board of Directors recommends voting in favor of both proposals.

Board of directors and corporate governance

• Chairman of the Board, Dr. Rodney S. Markin, authorized the notice and proxy materials.